Lifeboat Foundation

Amid ongoing human clinical trials, there is still a long way to go before neural chips are commonplace in clinics.

Neuroscientists at Stanford have linked Alzheimer’s disease to the disruption of brain metabolism via the kynurenine pathway, which is affected by amyloid plaque and tau proteins.

Their research has demonstrated that drugs blocking this pathway can restore cognitive function in Alzheimer’s mice by improving brain metabolism. This discovery not only bridges the gap between neuroscience and oncology but also provides a fast track to repurposing existing drugs for Alzheimer’s treatment.

Alzheimer’s disease and brain energy metabolism.

Summary: Researchers have identified a link between brain overgrowth and the severity of social and communication symptoms in children with autism spectrum disorder (ASD).

By analyzing MRI scans and conducting experiments with brain organoids, the study found that children with the most severe ASD symptoms had significantly larger brains. This enlargement is associated with altered activity of the enzyme Ndel1, which plays a crucial role in neuron development.

The findings open new avenues for understanding ASD and its varying symptom severity.

A study appearing in Journal of Bioethical Inquiry explored the legal and ethical challenges expected to arise in human brain organoid research.

Human brain organoids are three-dimensional neural tissues derived from stem cells that can mimic some aspects of the human brain. Their use holds incredible promise for medical advancements, but this also raises complex ethical and legal questions that need careful consideration.

Seeking to examine the various legal challenges that might arise in the context of human brain organoid research and its applications, the team of researchers, which included a legal scholar, identified and outlined potential legal issues.

Further, “the necessity to secure private ideas, plans, and brain data from unpermitted viewing is accorded to Dr. Anita S Jwa by the phrase,” she argues. Besides that, the ethical implications in the fields of informed consent, coercion, and fairness with respect to the common attributes of the BCIs must be critically considered. For example, consider a scenario where a BCI is used to control a prosthetic limb. Without proper privacy measures, “unauthorised access to the BCI could lead to manipulation of the prosthetic limb,” posing risks to the user’s safety and autonomy.

Overcoming these difficulties requires the joint efforts of all the stakeholders, such as researchers, policymakers, and industry leaders. In the same way, we have to critically assess the technical, ethical, and accessibility issues in BCI. We may then be able to capture the potential of these BCIs and ultimately improve human lives.

In this instance, just imagine that we are submerging into the future of BCIs, and to my surprise, it feels like living in a movie where sci-fi is a reality! BCIs are going to be able to do all kinds of really advanced things very soon. People are going to think that they are very cool. We are entering an entirely new realm of brainy gadgets that are becoming smaller, sleeker, and oh-so-wearable. It is now all gear change; the future of BCI is almost as organic as slipping on your dream pair of sunglasses.

Yesterday Daniel Dennett died. He was 82, about the same age as my father when he died a few years ago.

Rice University researchers have developed a new implantable sensor, spinalNET, capable of recording the electrical activity of spinal neurons in freely moving subjects. This breakthrough could help unlock the complexities of how spinal neurons process sensory and motor functions, potentially leading to better treatments for spinal cord diseases and injuries.

Implantable technologies have significantly improved our ability to study and even modulate the activity of neurons in the brain. However, neurons in the spinal cord are harder to study in action.

“If we understood exactly how neurons in the spinal cord process sensation and control movement, we could develop better treatments for spinal cord disease and injury,” said Yu Wu, a research scientist who is part of a team of Rice University neuroengineers working on a solution to this problem.

University of Queensland researchers have discovered a mechanism in DNA that regulates how disease-causing mutations are inherited.

Dr Anne Hahn and Associate Professor Steven Zuryn from UQ’s Queensland Brain Institute said the findings could provide a promising therapeutic avenue to stop the onset of heritable and age-related diseases.

“Mitochondrial DNA is essential for cell function,” Dr Hahn said.

Dr. Matt Lyon, MD: “We are not entirely sure what causes these issues with vision, but we suspect it has to do with a shift in cerebrospinal fluid in the optic nerve sheath. On Earth, gravity pushes that fluid down and it drains out, but in space, it floats up and presses against the optic nerve and retina.”

How does spaceflight affect vision loss in astronauts for both the short and long term? This is what a combined effort between the upcoming Polaris Dawn mission and the Medical College of Georgia (MCG) at Augusta University hopes to achieve as the four-person crew will be using a portable ultrasound machine to study changes in vision during spaceflight. This is especially prevalent since the four-person crew will be traveling in an elliptical orbit 870 miles above the Earth’s surface, exposing them to the Van Allen radiation belt, which is a highly radiated region of space between the Earth and the Moon.

For context, the International Space Station orbits approximately 250 miles above the Earth, and this research holds the potential to further explore the effects of space radiation on the human body, and specifically vision loss.

Continue reading “Mitigating Spaceflight Vision Risks: The Role of Portable Ultrasound in Polaris Dawn” »